Cancers, Vol. 12, Pages 671: Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
Conclusion: This study serves as additional evidence supporting the beneficial inhibitory effect of statins on HCC incidence. The subgroup analyses of this study also highlight that statins are significantly associated with a reduced risk of HCC and may help to direct future prevention efforts. Additional large clinical studies are needed to determine whether statins are associated with a lower risk of HCC.
Source: Cancers - Category: Cancer & Oncology Authors: Islam Poly Walther Yang (Jack) Li Tags: Review Source Type: research
More News: Antiviral Therapy | Cancer | Cancer & Oncology | Carcinoma | Cholesterol | Cirrhosis | Diabetes | Endocrinology | Hepatocellular Carcinoma | Liver | Liver Cancer | Science | Statin Therapy | Statistics | Study | Urology & Nephrology